The monoclonal antibody appears to target the same inhibition of the GSK-3 beta pathway. Mr.
单克隆抗体显示为目标的GSK - 3的测试通路相同的抑制作用。
Therefore, targeting GSK-3 may provide a promising treatment for the nervous system diseases.
因而，GSK - 3可望成为治疗神经系统疾病的新靶点。
MAIN OUTCOME MEASURES: The degree of NF phosphorylation and the activities of GSK-3 and CDK-5 were mainly observed.
主要观察指标：神经细丝的磷酸化程度及糖原合酶激酶3、细胞周期依赖性蛋白激酶5的酶活性。
应用推荐